| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. | J Clin Oncol | 2010 | 13.03 |
| 2 | Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer. | J Clin Oncol | 2010 | 1.83 |
| 3 | The value of label recommendations: how to dose lapatinib. | J Clin Oncol | 2007 | 0.79 |